* Neuralstem - New cohort of four patients will be added to ongoing phase 1 human clinical trial for NSI-566 spinal cord-derived neural stem cells * Neuralstem - Amended protocol was approved by U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results